Literature DB >> 17337734

Secondary exposure for 73 and 200 MeV proton therapy.

F Trompier1, S Delacroix, I Vabre, F Joussard, J Proust.   

Abstract

Following modifications on the beam line at the Orsay Protontherapy Center, dose measurements were performed in order to make a dose map in the treatment rooms and in the delimited radiation-controlled area around beam line. Measurements were performed using tissue-equivalent proportional counters and rem-counters. Analysis of TEPC single event measurements showed that high LET components (>10 keV.microm(-1)) represent 90 to 99% of total dose equivalent in the treatment rooms and 50 to 90% in the controlled area and quality factors range, respectively between 2 and 15. A fast neutron component was identified in the treatment rooms, where dose equivalent rate varied between few microSv.h(-1) to some dozen of mSv.h(-1). In high-energy radiation field rem-counters underestimated TEPC values for neutron component. The variation between instruments response according to the location is linked to energetic spectrum variations and instrument characteristics.

Mesh:

Substances:

Year:  2007        PMID: 17337734     DOI: 10.1093/rpd/ncm154

Source DB:  PubMed          Journal:  Radiat Prot Dosimetry        ISSN: 0144-8420            Impact factor:   0.972


  2 in total

1.  Neutron Radiation Dose Measurements in a Scanning Proton Therapy Room: Can Parents Remain Near Their Children During Treatment?

Authors:  Vladimir Mares; Jad Farah; Marijke De Saint-Hubert; Szymon Domański; Carles Domingo; Martin Dommert; Magdalena Kłodowska; Katarzyna Krzempek; Michał Kuć; Immaculada Martínez-Rovira; Edyta Michaś; Natalia Mojżeszek; Łukasz Murawski; Ondrej Ploc; Maite Romero-Expósito; Marco Tisi; François Trompier; Olivier Van Hoey; Laurent Van Ryckeghem; Marek Wielunski; Roger M Harrison; Liliana Stolarczyk; Pawel Olko
Journal:  Front Oncol       Date:  2022-07-14       Impact factor: 5.738

2.  Simulation and experimental verification of ambient neutron doses in a pencil beam scanning proton therapy room as a function of treatment plan parameters.

Authors:  Olivier Van Hoey; Liliana Stolarczyk; Jan Lillhök; Linda Eliasson; Natalia Mojzeszek; Malgorzata Liszka; Ali Alkhiat; Vladimir Mares; François Trompier; Sebastian Trinkl; Immaculada Martínez-Rovira; Maite Romero-Expósito; Carles Domingo; Ondrej Ploc; Roger Harrison; Pawel Olko
Journal:  Front Oncol       Date:  2022-09-08       Impact factor: 5.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.